The US Market for OTC Gastrointestinal Products is a comprehensive analysis of the impact OTC drugs have made to the gastrointestinal market. This study provides a detailed market size analysis for the years 1996 - 2000 and market forecasts to the year 2006. Within the OTC Gastrointestinal Product Market three market segments are covered, including: Antacids, H2 Receptor Antagonists, and Other Gastrointestinal Products. A thorough description of upper gastrointestinal conditions and diseases, treatments, and preventive care are included in this study. Trends covered in the report include dual regulatory status, consumer interests in self-medication, and impact of direct-to-consumer advertising. The US Market for OTC Gastrointestinal Products will provide the reader with a comprehensive analysis of gastrointestinal products currently marketed products potentially entering the market. The study focuses on the direction this market is taking and the contributing factors for continued growth. Detailed profiles of major competitors are provided.
Scope and Methodology
The U.S. market for OTC Gastrointestinal Products study focuses on three general product categories, which include:
The report describes the product categories in detail and the major market factors in each category. The report describes the industry, its relationship to various healthcare delivery channels, and trends for the future. The geographic scope of the report is the United States.
The research conducted by Kalorama Information included comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Person-to-person and telephone interviews were the primary method of gathering information. Interviews with over 50 key industry officials, trade association spokespersons, consultants, health care providers, and government personnel were complied to form the primary basis of information - specifically revenue and market share data - presented in this report.
All market data pertains to the US market at the manufacturers’ level. The base year for data was 2000. Historical data are provided for 1996 through 1999, with forecast data provided for 2001 through 2006. Compound annual growth rates (CAGRs) are provided for the 1996-1999, 2000-2006, and 1996-2006 periods for each industry segment covered.
Press Release: The U.S. Market for OTC Gastrointestinal Products
“The U.S. Market for OTC Gastrointestinal Products to Reach Nearly $4 Billion by 2006”
New York, May 16, 2001 /PRNewswire -- The market for OTC gastrointestinal products is projected to grow to $3.9 billion by 2006, with H2-receptor antagonists leading the way, according to a study released today by Kalorama Information, a division of MarketResearch.com.
The study, The U.S. Market for Gastrointestinal Products, reveals how H2-receptor antagonists, such as Tagamet HB, Zantac 75, and Pepcid AC, which began over the-counter sales in 1995, drove growth in the segment over the past 6 years, while steadily encroaching on the market share of traditional antacid products, such as Tums and Rolaids. The H2-receptor antagonists are expected to represent nearly half of the entire OTC gastrointestinal market by 2006.
“In addition to the introduction of the H2-receptor antagonists, an aging population, an ever increasing interest in self care, cost-saving pressures in the healthcare system, and a significant amount of direct consumer advertising have fueled the expansion of the market,” notes Steven Heffner, an editor at Kalorama Information. “And there are many more issues for the industry to confront in the next few years, from changes in the distribution system to generic activity and the big one—the potential arrival of PPIs on drugstore shelves.” PPIs, or proton-pump inhibitors, are yet another therapeutic class of prescription drugs that may gain OTC status in the next few years.
A detailed study of three product categories currently on the OTC Gastrointestinal Market—antacids, H2 receptor antagonists, and other products—the report combines extensive primary research and exhaustive secondary research to provide a comprehensive picture of a changing industry. The report thoroughly analyzes the trends and challenges in the segment provides and market size, growth, and share through 2006.
Kalorma Information (KLI), a division of MarketResearch.com, reports supply the latest in pharmaceutical research, exploring treatments and technology, legislation, regulation and ideological trends.
MarketResearch.com is the leading provider of global market intelligence products and services. With over 40,000 research publications from more than 350 top consulting and advisory firms, we offer instant online access to the world’s most extensive database of expert insights on global industries, companies, products and trends. Updated daily. For more information, contact Kim Bolus at 212.807.2655 or firstname.lastname@example.org, or visit www.MarketResearch.com.
The U.S. Market for Gastrointestinal Products Expected to Reach $4 Billion by the Year 2006
New! The U.S. Market for OTC Gastrointestinal Products report, published by Kalorma Information is now available through MarketResearch.com. The market for over-the-counter gastrointestinal products reached $2.6 billion in manufacturer’s revenue’s in 2000 and the market is expected to reach over $4 billion by 2006.
This report is a comprehensive analysis of the impact OTC drugs had on the gastrointestinal market. The study provides a detailed market size analysis for the years 1996 -2000 and projected market forecasts to the year 2006. This study focuses on the U.S. market in three general categories:
Growth in the OTC market for gastrointestinal products has been to some extent, and will continue to be, fueled by several driving factors such as; prescription to over the counter switches of H2 receptor antagonists, a continued aging of the population, an ever increasing interest in self care, the desire of both patients and third party payers for total cost saving in the healthcare system, and a significant amount of direct consumer advertising.
In addition those factors contributing to growth in the market, there are several other issues and trends currently affecting the OTC gastrointestinal market which are detailed in the report, including:
As well as many other factors that will be thoroughly examined in this report. This in-depth report includes both secondary and primary research. Primary research was compiled with person to person and telephone interviews with over 50 key industry officials, trade association spokespersons, consultants, healthcare providers, and government personnel to form information specifically for revenue and market share data.
Kalorama Information reports supply the latest in pharmaceutical research, exploring treatments and technology, legislation, regulation and ideological trends.
The U.S. Market for OTC Gastrointestinal Products report is available through MarketResearch.com, the leading provider of global market intelligence products and services. With MarketResearch.com, you can purchase The U.S. Market for OTC Gastrointestinal Products report as a complete study, or buy discrete segments using the options below:
Tables and Graphs:
H2 Receptor Antagonists
Other OTC Gastrointestinal Products
Issues And Trends Affecting The OTC Gastrointestinal Product Market
Total Market Size And Forecast
Company Names And Addresses
List of Exhibits
Chapter One: Executive Summary
Chapter Two: Introduction
Chapter Three: Antacids
Chapter Four: H2 Receptor Antagonists
Chapter Five: OTC Other Gastrointestinal Products
Chapter Six: Issues And Trends Affecting The OTC Gastrointestinal Product Market
Chapter Seven: Total Market Size And Forecast
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook